Prognostic value of circulating tumor cellsin nonmuscle invasive bladder cancer: Acellsearch analysis

Annals of Oncology

Volumn 23, Issue 9, 2012, Pages 2352-2356

  Gazzaniga, P ^a   Gradilone, A ^a   De berardinis, E ^b   Busetto, G M ^b   Raimondi, C ^a   Gandini, O ^a   Nicolazzo, C ^a   Petracca, A ^a   Vincenzi, B ^c   Farcomeni, A ^a   Gentile, V ^b   Cortesi, E ^b   Frati, L ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

CellSearch; CTCs; NMIBC; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CARCINOMA IN SITU; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84864853480     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr619     Document Type: Article

References (14)

1. Van den Bosch S, Alfred Witjes J. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 2011; 60(3): 493-500.
2. Zhe X, Cher ML, Bonfil RD. Circulating tumor cells: finding the needle in the haystack. Am J Cancer Res 2011; 1(6): 740-751.
3. Miller MC, Doyle GV, Terstappen LW. Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer. J Oncol 2010; 2010: 617421.
4. Pantel K, Alix-Panabières C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med 2010; 16(9): 398-406.
5. Pantel K, Alix-Panabières C, Riethdorf S. Cancer micrometastases. Nat Rev Clin Oncol 2009; 6(6): 339-351.
6. Naoe M, Ogawa Y, Morita J et al. Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 2007; 109(7): 1439-1445.
7. Gallagher DJ, Milowsky MI, Ishill N et al. Detection of circulating tumor cells in patients with urothelial cancer. Ann Oncol 2009; 20(2): 305-308.
8. Rink M, Chun FK, Minner S et al. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer. BJU Int 2011; 107(10): 1668-1675.
9. Sylvester RJ, van der Meijden APM, Oosterlinck W et al. Predicting recurrence and progression in individual patients with stage ta t1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-477.
10. Rack BK, Schindlbeck C, Andergassen U et al. Use of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: the SUCCESS trial. J Clin Oncol 2010; 28: 15s.
11. Msaouel P, Koutsilieris M. Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis. BMC Cancer 2011; 11: 336.
12. Gradilone A, Petracca A, Nicolazzo C et al. Prognostic significance of survivinexpressing circulating tumour cells in T1G3 bladder cancer. BJU Int 2010; 106 (5): 710-715.
13. Tilki D, Burger M, Dalbagni G et al. Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Eur Urol 2011; 60(3): 484-492.
14. Youssef RF, Lotan Y. Predictors of outcome of non-muscle-invasive and muscleinvasive bladder cancer. Sci World J 2011; 11: 369-381.